BELLICUM PHARMACEUTICALS, INC Quarterly Interest Expense in USD from Q1 2014 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Bellicum Pharmaceuticals, Inc quarterly/annual Interest Expense history and growth rate from Q1 2014 to Q3 2022.
  • Bellicum Pharmaceuticals, Inc Interest Expense for the quarter ending September 30, 2022 was $0.000.
  • Bellicum Pharmaceuticals, Inc Interest Expense for the twelve months ending September 30, 2022 was -$1K, a 101% decline year-over-year.
  • Bellicum Pharmaceuticals, Inc annual Interest Expense for 2021 was $4K, a 99.9% decline from 2020.
  • Bellicum Pharmaceuticals, Inc annual Interest Expense for 2020 was $2.66M, a 37.9% decline from 2019.
  • Bellicum Pharmaceuticals, Inc annual Interest Expense for 2019 was $4.28M, a 1.93% increase from 2018.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$1K $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 -$1K $0 -$1K -100% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $0 $0 -$4K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $4K -$1K -$187K -101% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-24
Q3 2021 $191K $0 -$725K -100% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $916K $1K* -$762K -99.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.68M $4K -$981K -99.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.66M $186K -$857K -82.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 $3.52M $725K -$354K -32.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $3.87M $763K -$325K -29.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $4.2M $985K -$85K -7.94% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $4.28M $1.04M -$43K -3.96% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $4.32M $1.08M +$14K +1.32% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $4.31M $1.09M +$43K +4.12% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $4.27M $1.07M +$67K +6.68% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $4.2M $1.09M +$121K +12.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 $4.08M $1.07M +$55K +5.45% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $4.02M $1.05M +$69K +7.07% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $3.95M $1M +$282K +39.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $3.67M $965K +$328K +51.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 $3.34M $1.01M +$495K +96.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $2.85M $976K +$490K +101% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $2.36M $721K +$599K +491% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $1.76M $637K +$625K +5208% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 $1.14M $515K +$515K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $620K $486K +$486K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $134K $122K +$122K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 $12K $12K -$1.74M -99.3% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-13
Q3 2015 $1.75M $0 -$11K -100% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $1.76M $0 -$11K -100% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $1.78M $0 -$16K -100% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $1.79M $1.75M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-13
Q3 2014 $11K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $11K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $16K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.